Analysts: Walgreens Shows Long-Term Prospects and 3 Other Research Notes to Peruse

Walgreens (NYSE:WAG): Morgan Stanley upgraded Walgreens to Overweight from Equal Weight. The firm upgraded shares based on 2016 fiscal year growth prospects when the Alliance Boots deal is completed, deal synergies, and coverage expansion. The shares’ price target is $70.

wag-20130923

Catamaran (NASDAQ:CTRX): Credit Suisse notes Catamaran said that exchange risk concerns are overdone, and that above-average growth is sustainable. The firm expects Catamaran to continue to take share and consolidate mid-market PBMs, and recommends investors use the weakness as a buying opportunity. The shares are Outperform rated with a $64 price target.

ctrx-20130923

Avago Technologies (NASDAQ:AVGO): Canaccord says that teardown analysis of the iPhone 5S and 5C indicates that Avago has maintained strong RF dollar content. The firm continues to believe Avago is well-positioned given its strong proprietary technologies, strong IP portfolio, and diverse customer base. The shares are Buy rated with a $53 price target, up from $45.

avgo-20130923

Xerox (NYSE:XRX): Brean Capital introduced 2015 estimates predicated on capital returns including stock buybacks, increased dividend yields, and Services margin improvements. The shares are Buy rated and the price target has been raised to $12.50 from $11.40.

xrx-20130923

Don’t Miss: CBO: We Have a Tax Problem, Not a Spending Problem.

More Articles About:   , , , ,  

More from The Cheat Sheet